All Videos

Dr Mark Lebwohl provides insight into the educational needs of both patients and providers surround the utilization of spesolimab and its importance in the management of patients with generalized pustular psoriasis.

Mark G. Lebwohl, MD, comments on the clinical implications of the recent approval of spesolimab for the treatment of generalized pustular psoriasis.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, explore the burden of itch in atopic dermatitis, and why JAK inhibitors may be able to provide relief.

An expert in dermatology presents the case of a 64-year-old female with a long history of plaque psoriasis, focusing on her disease severity and age-related management considerations.

Expert dermatologists discuss the risk of candidiasis with IL-17 inhibitors when managing plaque psoriasis and how to manage candidiasis.

Drs Mark G. Lebwohl and Alice B. Gottlieb discuss the novel mechanism of bimekizumab and how it can change the treatment landscape for plaque psoriasis.

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews RoC's Fill + Treat Serum.

November kicks off National Healthy Skin Month, presenting an opportunity to learn new habits for healthier skin.

Valisure, an independent laboratory, recently sent a Citizen's Petition to the FDA regarding high levels of benzene found in dry shampoo products.

Goals of generalized pustular psoriasis treatment are reviewed by Dr Mark Lebwohl, where he comments on the need to consider patient disease severity and comorbidities.

Dr Mark Lebwohl comments on the treatment and management considerations for a patient suffering from severe generalized pustular psoriasis, highlighting the inefficiency of systemic steroids in the management of this condition.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, talk about the use of oral systemic agents and what they’ve learned about the patient experience from the use of these agents.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, examine the clinical context for the approval of topical ruxolitinib and its role in the treatment armamentarium.

Mark G. Lebwohl, MD, introduces the case of a 28-year-old female nurse with a long history of psoriasis, commenting on her past medical history and initial presentation.

Mark G. Lebwohl, MD, and Alice B. Gottlieb, MD, PhD, discuss the durability of IL-17 inhibitors in managing plaque psoriasis.

Expert dermatologists discuss how to select treatment for plaque psoriasis while taking comorbidities into consideration.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses a rare form of skin cancer, Merkel cell carcinoma.

Thought leaders discuss why JAK inhibitors are well suited for the management of itch and inflammation in the treatment of moderate to severe atopic dermatitis.

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, review the recent trajectory of the atopic dermatitis therapeutic spectrum, notably how several newer approvals have changed how clinicians approach treatment.

Drs Mark G. Lebwohl and Alice B. Gottlieb discuss how to select treatment for plaque psoriasis based on mechanism of action.

Mark G. Lebwohl, MD, and Alice B. Gottlieb, MD, PhD, discuss pathogenesis of plaque psoriasis and new emerging targets.

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews the social media phenomenon of "dermarolling."

Christopher Bunick, MD, PhD, discusses the 5th personal care product category recall, dry shampoos, due to heightened levels of benzene.

Neal D. Bhatia, MD, discusses the nuances of photodynamic therapy in a session at Fall Clinical in Las Vegas, Nevada, October 20-23.

Data demonstrates an increase in the proportion of patients achieving regimentation with longer duration of ruxolitinib cream treatment.

At the 2022 Fall Clinical Conference in Las Vegas, Nevada, Dermatology Times editor-in-chief, Zoe Diana Draelos, discusses her session on the latest trends in cosmeceuticals.

As the 2022 Fall Clinical Dermatology Conference begins this week, Heathy Ivy, DO, regional medical director for LaserAway in Atlanta, Georgia, shares why she is looking forward to attending Fall Clinical.

Matt Leavitt, DO, FAOCD, discusses highlights of his session on "Evalulating the Patient With Hair Loss" at this year's Fall Clinical conference in Las Vegas Nevada, October 20-23.

Raj Chovatiya, MD, PhD, assistant professor of dermatology and Medical Director, Center for Eczema and Itch and Medical Director, Clinical Trials Unit at the Northwestern University Feinberg School of Medicine in Chicago, Illinois, shares highlights from his upcoming presentations at Fall Clinical in Las Vegas, Nevada, October 20-23, 2022.

Lisa Swanson, MD, FAAD, a pediatric dermatologist in Boise, Idaho, presents all that is new and hot in pediatric dermatology at the 2022 Fall Clinical Conference in Las Vegas Nevada, October 20-23.